Literature DB >> 24775275

Evaluation of three medetomidine-based protocols for chemical restraint and sedation for non-painful procedures in companion rats (Rattus norvegicus).

Luca Bellini1, Tommaso Banzato1, Barbara Contiero1, Alessandro Zotti2.   

Abstract

Three medetomidine-based protocols were evaluated for sedation in companion rats undergoing diagnostic procedures. Group Me received medetomidine at 150 μg/kg intramuscularly (IM); group Me-Bu received medetomidine 100 μg/kg IM and butorphanol 2 mg/kg IM, and group Me-Bu-Mi received medetomidine 50 μg/kg IM, butorphanol 2 mg/kg IM and midazolam 1 mg/kg IM. The righting reflex disappeared more quickly in the Me-Bu-Mi group, but recovery after atipamezole was longer. In group Me, a palpebral reflex was present throughout sedation in more rats than in the other two groups. Pulse and respiratory rates were higher when lower doses of medetomidine were used, although arterial haemoglobin O2 saturation was similar among groups. All protocols tested produced adequate sedation lasting 25 min.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Butorphanol; Medetomidine; Midazolam; Rats; Sedation

Mesh:

Substances:

Year:  2014        PMID: 24775275     DOI: 10.1016/j.tvjl.2014.03.024

Source DB:  PubMed          Journal:  Vet J        ISSN: 1090-0233            Impact factor:   2.688


  2 in total

1.  Effects of an anesthetic mixture of medetomidine, midazolam, and butorphanol in rats-strain difference and antagonism by atipamezole.

Authors:  Yumiko Kirihara; Mayumi Takechi; Kaoru Kurosaki; Yuta Kobayashi; Yoji Saito; Takashi Takeuchi
Journal:  Exp Anim       Date:  2015-09-29

2.  Comparison of the anesthetic effect by the injection route of mixed anesthesia (medetomidine, midazolam and butorphanol) and the effect of this anesthetic agent on the respiratory function.

Authors:  Hiromi Shibuta; Rei Yamana; Junko Kashimoto; Kyohei Kamio; Akiko Suda
Journal:  J Vet Med Sci       Date:  2019-11-21       Impact factor: 1.267

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.